QurAlis is bringing hope to the ALS community by developing breakthrough precision medicines for this devastating disease. Our stem cell technologies generate proprietary human neuronal models that enable us to more effectively discover and develop innovative therapies for genetically validated targets. We are advancing three therapeutic programs addressing sub-forms of ALS that account for the majority of patients. With our world-class network of thought leaders, drug developers and patient advocates, our team is rising to the challenge of conquering ALS.